(Type 2 Diabetes, Hypertension, Dyslipidaemia, or OSA)
Verified
Last Review: 2026
Jensen MD et al. • Circulation. 2014;The foundational guideline for evidence-based obesity management and pharmacological eligibility.
Last Comprehensive Review: 2026
Clinical Context
We think this has broad domain relevance to Obesity Pharmacotherapy Eligibility.
Clinical Context
We think this has broad domain relevance to Obesity Pharmacotherapy Eligibility.
Clinical Context
We think this might be relevant to the clinical guidance for Obesity Pharmacotherapy Eligibility.
